已收盤 02-06 16:00:00 美东时间
+0.090
+2.81%
LF entscheidet sich für Rimini Street als Support-Dienstleister für SAP und Oracle Systeme Rimini Street Inc. hat bekannt gegeben, dass LF, ein Unternehmen aus Südkorea, Rimini Support für die Wartung von SAP ECC 6.0 und Oracle Database Systemen ausgewählt hat. LF konsolidiert mit Rimini Street den
02-03 22:00
LF Selects Rimini Street for SAP and Oracle Support Rimini Street, Inc. announced that LF, a leading lifestyle company in South Korea, has selected Rimini Support to optimize maintenance for its SAP ECC 6.0 and Oracle Database systems. The agreement is aimed at enhancing LF's operational stability a
02-03 22:00
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the immediate availability of
01-22 22:06
Rimini Street (RMNI) repurchased 975,000 shares in Q4 2025 for $3.8M at an average price of $3.92, reducing outstanding shares by ~1.1%. The company has completed $13.3M in repurchases under its $50M ...
2025-12-02 00:12
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and
2025-11-18 22:07
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
2025-11-03 20:20
Rimini Street shares are trading lower after the company reported worse-than-ex...
2025-10-31 21:27
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Rimini Street 2025年第三季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 第三季度营收1.034亿美元,同比下降1.2%。剔除Oracle PeopleSoft服务收入后,核心业务营收同比增长2.5%。国际业务占总营收的55%,美国业务占45%。 **盈利能力:** 毛利率为59.9%,较去年同期的60.7%有所下降。Non-GAAP毛利率为60.4%,低于去年同期的61.1%。净利润方面,GAAP净利润为280万美元(每股0.03美元),而去年同期为净亏损(每股-0.47美元)。Non-GAA
2025-10-31 12:31
Rimini Street (NASDAQ:RMNI) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.09 by 18.6 percent. This is a 68.18 percent decrease over earnings of $0.22 per share from the
2025-10-31 04:03
今日重点评级关注:花旗:维持Arcus Biosciences"买入"评级,目标价从47美元升至54美元;HC Wainwright & Co.:上调Karyopharm Therapeutics评级至"买入",目标价15美元
2025-10-14 09:56